Skip to main content
SpringerLink
Log in

Trends of Biogenic Nanoparticles in Lung Cancer Theranostics

  • Chapter
  • First Online:
Emerging Nanomaterials for Advanced Technologies

Part of the book series: Nanotechnology in the Life Sciences ((NALIS))

  • 905 Accesses

Abstract

Nanotechnology has revolutionized the field of medicinal sciences. Different approaches have emerged through time to successfully synthesize nanoparticles (NPs) that are safe, less toxic, and environmental friendly. Biogenic routes involving agents such as plants and microbes promote the circumstances to design NPs with low toxicity and unique properties. Lung cancer is one among the most fatal diseases that has high mortality rate globally. Diagnosis of cancer in late stages has often resulted in the decrease of survival opportunity of the patients. Further, nonspecific targeting of the drugs, poor solubility, bio-incompatibility, toxicity, extended accumulation, and side effects are the major limitations of conventional cancer therapy. A reliant and efficient theranostic candidate is required to overcome the shortcomings and to aid in better treatment of the patients. NPs are acknowledged as promising candidates in the medicinal field, yet a clear understanding of the nanoparticle mechanism and functions is necessary to identify them as potent inhibitory agents of lung cancer. Hence, the molecular aspects of lung cancer and the limitations of conventional cancer therapies, along with the role of biogenic NPs in lung cancer theranostics, their recent trends, the challenges they possess, and future aspects, are briefed in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ahmad MB, Tay MY, Shameli K, Hussein MZ, Lim JJ (2011) Green synthesis and characterization of silver/chitosan/polyethylene glycol nanocomposites without any reducing agent. Int J Mol Sci 12:4872–4884

    Article  PubMed  PubMed Central  Google Scholar 

  • Akintelu SA, Folorunso AS, Folorunso FA, Oyebamiji AK (2020) Green synthesis of copper oxide nanoparticles for biomedical application and environmental remediation. Heliyon 6(7):e04508

    Article  PubMed  PubMed Central  Google Scholar 

  • Babu A, Templeton AK, Munshi A, Ramesh R (2013) Nanoparticle-based drug delivery for therapy of lung cancer: progress and challenges. J Nanomater 2013:1–11

    Article  Google Scholar 

  • Bandyopadhyay A, Das T, Yeasmin S (2015) Nanoparticles in lung cancer therapy. In: Recent trends Springer Briefs in molecular science. ISSN No:978-81-322-2175-3, pp. 17–26

    Google Scholar 

  • Bhattacharyya S, Kudgus R, Bhattacharya R, Mukherjee P (2011) Inorganic nanoparticles in cancer therapy. Pharm Res 28:237–259

    Article  CAS  PubMed  Google Scholar 

  • Burstein HJ, Schwartz RS (2008) Molecular origins of cancer. N Engl J Med 358(5):527–527

    Article  CAS  PubMed  Google Scholar 

  • Byers LA, Rudin CM (2014) Small cell lung cancer: where do we go from here? Cancer 121(5):664–672

    Article  PubMed  Google Scholar 

  • Cooper WA, Lam DCL, O’Toole SA, Minna JD (2013) Molecular biology of lung cancer. J Thorac Dis 5(S5):S479–S490

    PubMed  PubMed Central  Google Scholar 

  • Cryer AM, Thorley AJ (2019) Nanotechnology in the diagnosis and treatment of lung cancer. Pharmacol Ther 198:189–205

    Article  CAS  PubMed  Google Scholar 

  • Galbiati A, Tabolacci C, Morozzo Della Rocca B, Mattioli P, Mattioli S, Beninati G, Paradossi G, Desideri A (2011) Targeting tumor cells through chitosan-folate modified microcapsules loaded with camptothecin. Bioconjug Chem 22:1066–1072

    Article  CAS  PubMed  Google Scholar 

  • Gridelli C, Rossi A, Carbone DP, Guarize J, Karachaliou N, Mok T, Rosell R (2015) Non-small-cell lung cancer. Nat Rev Dis Primers 1:15009

    Article  PubMed  Google Scholar 

  • Hariharan D, Srinivasan K, Nehru LC (2017) Synthesis and characterization of Tio 2 nanoparticles using CynodonDactylon leaf extract for antibacterial and anticancer (A549 cell lines) activity. J Nanomed Res 5(6):00138

    Google Scholar 

  • He Y, Du Z, Ma S, Liu Y, Li D, Huang H, Zheng X (2016) Effects of green-synthesized silver nanoparticles on lung cancer cells in vitro and grown as xenografttumors in vivo. Int J Nanomedicine 11:1879

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Howell M, Wang C, Mahmoud A, Hellermann G, Mohapatra SS, Mohapatra S (2013) Dual-function theranostic nanoparticles for drug delivery and medical imaging contrast: perspectives and challenges for use in lung diseases. Drug Deliv Transl Res 3(4):352–363

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jadhav UG (2012) Fabrication of polyherbal nanoparticles—a targetted herbal drug delivery. Pharm Anal Acta 3:121

    Google Scholar 

  • Jong WHD, Borm PJ (2008) Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine 3:133–149

    Article  PubMed  PubMed Central  Google Scholar 

  • Karkan FS, Mohammadhosseini M, Panahi Y, Milani M, Zarghami N, Akbarzadeh A, Davaran S (2016) Magnetic nanoparticles in cancer diagnosis and treatment: a review artificial cells. Nanomed Biotechnol 45(1):1–5

    Google Scholar 

  • Karmous I, Pandey A, Haj KB, Chaoui A (2019) Efficiency of the green synthesized nanoparticles as new tools in cancer therapy: insights on plant-based bioengineered nanoparticles, biophysical properties, and anticancer roles. Biol Trace Elem Res 196:330–342

    Article  PubMed  Google Scholar 

  • Kumar A, MazinderBoruah B, Liang XJ (2011) Gold nanoparticles: promising nanomaterials for the diagnosis of cancer and HIV/AIDS. J Nanomater 2011:1–17

    Google Scholar 

  • Larsen JE, Minna JD (2011) Molecular biology of lung cancer: clinical implications. Clin Chest Med 32:703–740

    Article  PubMed  PubMed Central  Google Scholar 

  • Lv PP, Wei W, Yue H, Yang TY, Wang LY, Ma GH (2011) Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration. Biomacromolecules 12:4230–4239

    Article  CAS  PubMed  Google Scholar 

  • Lynch TJ, Bell DW, Sordella R (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non–small-cell lung cancer to gefitinib. N Engl J Med 350:2129–2139

    Article  CAS  PubMed  Google Scholar 

  • Madamsetty VS, Mukherjee A, Mukherjee S (2019) Recent trends of the bio-inspired nanoparticles in cancer theranostics. Front Pharmacol 10:1264

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mao Y, Liu X (2020) Bioresponsive Nanomedicine: the next step of deadliest cancers’ theranostics. Front Chem 8:257

    Google Scholar 

  • Matsushita H, Morishita R, Nata T (2000) Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation. Circ Res 86(9):974–981

    Article  CAS  PubMed  Google Scholar 

  • Menon JU, Jadeja P, Tambe P, Vu K, Yuan B, Nguyen KT (2013) Nanomaterials for photo-based diagnostic and therapeutic applications. Theranostics 3(3):152–166

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mohanraj VJ, Chen Y (2006) Nanoparticles—a review. Trop J Pharm Res 5:561–573

    Google Scholar 

  • Moorthi C, Manavalan R, Kathiresan K (2011) Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J Pharm Pharm Sci 14(1):67–77

    Article  Google Scholar 

  • Mottaghitalab F, Farokhi M, Fatahi Y, Atyabi F, Dinarvand R (2019) New insights into designing hybrid nanoparticles for lung cancer: diagnosis and treatment. J Control Release 295:250–267

    Article  CAS  PubMed  Google Scholar 

  • Mukherjee A, Paul M, Mukherjee S (2019) Recent progress in the theranostics application of nanomedicine in lung cancer. Cancers 11(5):597

    Article  CAS  PubMed Central  Google Scholar 

  • Muthuraj B, Mukherjee S, Patra CR, Iyer PK (2016) Amplified fluorescence from Polyfluorene nanoparticles with dual state emission and aggregation caused red shifted emission for live cell imaging and cancer theranostics ACS. Appl Mater Interf 8:32220–32229

    Article  CAS  Google Scholar 

  • Narsireddy A, Anish B, Ranganayaki M, Anupama M, Rajagopal R (2017) Polymeric nanoparticle-mediated gene delivery for lung cancer treatment. Top Curr Chem 375(35):1–23

    Google Scholar 

  • Okamoto H, Nishida S, Todo H, Sakakura Y, Iida K, Danjo K (2003) Pulmonary gene delivery by chitosan–pDNA complex powder prepared by a supercritical carbon dioxide process. J Pharm Sci 92:371–380

    Article  CAS  PubMed  Google Scholar 

  • Padmini R, Razia M, Roopavahini R, Aruna S (2016) Molecular docking studies of Allylsulfur compounds from Allium sativum against EGFR receptor. Int J Curr Res Acad Rev 3:207–218

    Google Scholar 

  • Padmini R, Razia M, Sitrarasi R (2017) Molecular docking studies of bioactive compounds from Allium sativum against EML4-ALK receptor. Res J Pharm Technol 10(11):3741–3747

    Article  Google Scholar 

  • Padmini R, Uma Maheshwari V, Arun M, Razia M, Anand K, Ravindran B, Chung WJ (2020) Myricetin: versatile plant based flavonoid for cancer treatment by inducing cell cycle arrest and ROS–reliant mitochondria-facilitated apoptosis in A549 lung cancer cells and in silico prediction. Mol Cell Biochem 476(1):57–68

    Google Scholar 

  • Papp T, Schipper H, Pemsel H, Bastrop R, Muller KM, Wiethege T, Weiss DG, Dopp E, Schiffmann D, Rahman Q (2001) Mutational analysis of N-ras, p53, p16INK4a, p14ARF and CDK4 genes in primary human malignant mesotheliomas. Int J Oncol 18(2):425–433

    CAS  PubMed  Google Scholar 

  • Parvanian S, Mostafavi SM, Aghashiri M (2017) Multifunctional nanoparticle developments in cancer diagnosis and treatment. Sens Bio-Sens Res 13:81–87

    Article  Google Scholar 

  • Parvathi PV, Mahalingam U, Raj BR (2015) Improved waste water treatment by biosynthesized graphene sand composite. J Environ Manag 162:299e305

    Google Scholar 

  • Purushotham A, Bains S, Lewison G, Szmukler G, Sullivan R (2013) Cancer and mental health—a clinical and research unmet need. Ann Oncol 24(9):2274–2278

    Article  CAS  PubMed  Google Scholar 

  • Que YM, Fan XQ, Lin XJ, Jiang XL, Hu PP, Tong XY, Tan QY (2019) Size dependent anti-invasiveness of silver nanoparticles in lung cancer cells. RSC Adv 9(37):21134–21138

    Article  CAS  Google Scholar 

  • Rafique M, Sadaf I, Rafique M, Tahir MB (2017) A review on green synthesis of silver nanoparticles and their applications. Artif Cells 7:1–20

    Google Scholar 

  • Rani D, Somasundaram VH, Nair S, Koyakutty M (2012) Advances in cancer nanomedicine. J Indian Inst Sci 92:187–218

    CAS  Google Scholar 

  • Ratan ZA, Haidere MF, Nurunnabi M, Shahriar SM, Ahammad AJS, Shim YY, Cho JY (2020) Green chemistry synthesis of silver nanoparticles and their potential anticancer effects. Cancers 12(4):855

    Article  CAS  PubMed Central  Google Scholar 

  • Rezaie AB, Montazer M, Rad MM (2017) Photo and biocatalytic activities along with UV protection properties on polyester fabric through green in-situ synthesis of cauliflower-like CuO nanoparticles. J Photochem Photobiol B Biol 176:100–111

    Article  CAS  Google Scholar 

  • Sattler KD (2010) Handbook of nanophysics: nanomedicine and nanorobotics. CRC Press, Boca Raton

    Book  Google Scholar 

  • Sholl LM (2014) Large-cell carcinoma of the lung: a diagnostic category redefined by immunohistochemistry and genomics. Curr Opin Pulm Med 20:324–331

    Article  CAS  PubMed  Google Scholar 

  • Sivasankar M, Kumar BP (2010) Role of nanoparticles in drug delivery system. Int J Pharm Biomed Res 1:41–66

    Google Scholar 

  • Skocaj M, Filipic M, Petkovic J, Novak S (2011) Titanium dioxide in our everyday life; is it safe? Radiol Oncol 45(4):227–247

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stinchcombe TE (2014) Unmet needs in squamous cell carcinoma of the lung: potential role for immunotherapy. Med Oncol 31:960

    Article  PubMed  PubMed Central  Google Scholar 

  • Sukumar UK, Bhushan B, Dubey P, Matai I, Sachdev A, Packirisamy G (2013) Emerging applications of nanoparticles for lung cancer diagnosis and therapy. Int Nano Lett 3:45

    Article  Google Scholar 

  • Sun B, Hu N, Han L, Pi Y, Gao Y, Chen K (2019) Anticancer activity of green synthesised gold nanoparticles from Marsdeniatenacissima inhibits A549 cell proliferation through the apoptotic pathway. Artif Cells Nanomed Biotechnol 47:4012–4019

    Article  PubMed  Google Scholar 

  • Tran S, DeGiovanni PJ, Piel B, Rai P (2017) Cancer nanomedicine: a review of recent success in drug delivery. Clin Transl Med 6(1):44

    Google Scholar 

  • Travis WD (2012) Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas. Mod Pathol 25:S18–S30

    Article  CAS  PubMed  Google Scholar 

  • Vandermeers F, Hubert P, Delvenne P, Mascaux C, Grigoriu B, Burny A, Willems L (2009) Valproate, in combination with pemetrexed andcisplatin, provides additional efficacy to the treatment of malignant mesothelioma. Clin Cancer Res 15:2818–2828

    Article  CAS  PubMed  Google Scholar 

  • Wang T, Jiang H, Wan L (2015) Potential application of functional porous tio2 nanoparticles in light-controlled drug release and targeted drug delivery. Acta Biomater 13:354–363

    Article  CAS  PubMed  Google Scholar 

  • Wang C, Mathiyalagan R, Kim YJ, Castro-Aceituno V, Singh P, Sungeun A, Wang D, Yang DC (2016) Rapid green synthesis of silver and gold nanoparticles using Dendropanaxmorbifera leaf extract and their anticancer activities. Int J Nanomedicine 11:3691–3701

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yip PY, Yu B, Cooper WA (2013) Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma. J Thorac Oncol 8:408–414

    Article  CAS  PubMed  Google Scholar 

  • Yu Z, Pestell TG, Lisanti MP, Pestell RG (2012) Cancer stem cells. Int J Biochem Cell Biol 44:2144–2151

    Google Scholar 

  • Youssef Z, Vanderesse R, Colombeau L, Baros F, Roques-Carmes T, Frochot C, Gazzali AM (2017) The application of titanium dioxide, zinc oxide, fullerene, and graphene nanoparticles in photodynamic therapy. Cancer Nanotechnol 8(1):6

    Google Scholar 

  • Yusefi M, Shameli K, Ali RR, Pang SW, Teow SY (2019) Evaluating anticancer activity of plant-mediated synthesized Iron oxide nanoparticles using PunicaGranatum fruit Peel extract. J Mol Struct 1204:127539

    Article  Google Scholar 

  • Zheng Y, Zhang J, Zhang R, Luo Z, Wang C, Shi S (2019) Gold nano particles synthesized from Magnolia officinalis and anticancer activity in A549 lung cancer cells. Artif Cells Nanomed Biotechnol 47:3101–3109

    Article  CAS  PubMed  Google Scholar 

  • Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina-Pinelo S, Paz-Ares L (2016) Current challenges in cancer treatment. Clin Ther 38(7):1551–1566

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biotechnology, Mother Teresa Women’s University, Kodaikanal, Tamil Nadu, India

    V. Uma Maheshwari Nallal & M. Razia

  2. Department of Pharmacology and Environmental Toxicology, University of Madras, Chennai, Tamil Nadu, India

    C. Sumathi Jones

  3. Asan Memorial Dental College and Hospital, Chengalpattu, Tamil Nadu, India

    C. Sumathi Jones

  4. Department of Radiation Oncology, Chungbuk National University College of Medicine, Cheongju, Republic of Korea

    D. S. Prabakaran

  5. Department of Biotechnology, Ayya Nadar Janaki Ammal College, Sivakasi, Sivakasi, Tamil Nadu, India

    D. S. Prabakaran

  6. Product Development, Genus LifesciencesInc, Allentown, PA, USA

    Prakash Ramalingam

Authors
  1. V. Uma Maheshwari Nallal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Sumathi Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Razia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. S. Prabakaran
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Prakash Ramalingam
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Chemical Pathology, University of the Free State, Bloemfontein, Free State, South Africa

    Anand Krishnan

  2. Department of Environment Energy and Engineering, Kyonggi University, Suwon-si, Korea (Republic of)

    Balasubramani Ravindran

  3. Department of Food Science and Biotechnology, Sejong University, Seoul, Korea (Republic of)

    Balamuralikrishnan Balasubramanian

  4. Department of Physics, University of the Free State, Bloemfontein, South Africa

    Hendrik C. Swart

  5. School of Chemistry and Physics, University of KwaZulu Natal, Durban, South Africa

    Sarojini Jeeva Panchu

  6. Department of Botany, Mahatma Gandhi Central University/ Bihar, Motihari, Bihar, India

    Ram Prasad

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nallal, V.U.M., Jones, C.S., Razia, M., Prabakaran, D.S., Ramalingam, P. (2022). Trends of Biogenic Nanoparticles in Lung Cancer Theranostics. In: Krishnan, A., Ravindran, B., Balasubramanian, B., Swart, H.C., Panchu, S.J., Prasad, R. (eds) Emerging Nanomaterials for Advanced Technologies. Nanotechnology in the Life Sciences. Springer, Cham. https://doi.org/10.1007/978-3-030-80371-1_9

Download citation

Publish with us

Policies and ethics

Search

Navigation